Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of SMC1A mRNA | affects expression | 21346803
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of SMC1A mRNA | increases expression | 18648102
|
C035207 |
4-amino-2,6-dinitrotoluene |
4-amino-2,6-dinitrotoluene affects the expression of SMC1A mRNA | affects expression | 21346803
|
D000111 |
Acetylcysteine |
Acetylcysteine inhibits the reaction [Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of SMC1A protein]] | decreases reaction|increases phosphorylation|increases reaction | 15489221
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SMC1A mRNA | affects expression | 16483693
|
C074702 |
chromium hexavalent ion |
chromium hexavalent ion promotes the reaction [ATR protein results in increased phosphorylation of SMC1A protein] | increases phosphorylation|increases reaction | 16876463
|
C074702 |
chromium hexavalent ion |
chromium hexavalent ion results in increased phosphorylation of SMC1A protein | increases phosphorylation | 16876463
|
C074702 |
chromium hexavalent ion |
RAD17 protein affects the reaction [chromium hexavalent ion promotes the reaction [ATR protein results in increased phosphorylation of SMC1A protein]] | affects reaction|increases phosphorylation|increases reaction | 16876463
|
C074702 |
chromium hexavalent ion |
RAD17 protein affects the reaction [chromium hexavalent ion results in increased phosphorylation of SMC1A protein] | affects reaction|increases phosphorylation | 16876463
|
D004317 |
Doxorubicin |
Acetylcysteine inhibits the reaction [Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of SMC1A protein]] | decreases reaction|increases phosphorylation|increases reaction | 15489221
|
D004317 |
Doxorubicin |
Doxorubicin promotes the reaction [ATM protein results in increased phosphorylation of SMC1A protein] | increases phosphorylation|increases reaction | 15489221
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SMC1A mRNA | affects cotreatment|increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of SMC1A mRNA | decreases expression | 15576828
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of SMC1A mRNA | decreases expression | 18035473
|
C015329 |
lycopene |
lycopene results in decreased expression of SMC1A mRNA | decreases expression | 16886892
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of SMC1A mRNA | decreases expression | 17426115
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of SMC1A mRNA | decreases expression | 17101203
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SMC1A mRNA | affects cotreatment|increases expression | 17942748
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
4-amino-2,6-dinitrotoluene |
9.00 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.00 | 14514962 15322242 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.71 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.12 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.23 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.47 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.47 | 14692618 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
2.81 | 3712494 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.42 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.42 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.67 | 21441931 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.05 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.60 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.73 | 15885639 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
5.19 | 1440618 11289319 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.14 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.14 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.96 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.83 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.87 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.91 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.10 | 17983394 16826403 11325840 15136595 16096432 15994142 18628466 15939500 17369602 17426702 16115903 16264153 19526202 18382427 16595493 16935488 15567936 18234424 15692762 15634643 15668708 15993339 16322301 18695136 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.10 | 20435547 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.98 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.89 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
4.71 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
4.71 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
4.71 | 18059187 16234567 17876044 16023760 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
6.71 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
6.71 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Acetylcysteine |
5.23 | 17015178 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
5.23 | 6189445 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.42 | 16120746 18850075 18670907 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.60 | 15505089 17519947 16952015 18627295 16731534 17308081 17928571 17351982 17382496 17007740 17924179 16651473 16109756 16364871 15811867 16269455 17974986 17131338 15792986 15476868 16278810 17329180 16612575 16455267 16242529 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.98 | 17334414 16243910 |
MESH:D002386 |
Cataract |
|
4-amino-2,6-dinitrotoluene |
3.69 | 14694615 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
11.76 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
11.76 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Acetylcysteine |
11.76 | 18226522 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.26 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
13.85 | 9022650 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
13.85 | 16105132 16919318 11677210 15861022 17681005 17110522 17333356 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
13.85 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.14 | 16354765 15340226 8697196 12621046 15668235 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18259882 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
4-amino-2,6-dinitrotoluene |
9.52 | 15095906 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
9.52 | 14669216 17141729 |
MESH:C536442 |
Cornelia de Lange syndrome 2 |
marker/mechanism |
|
| |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 10048152 20055451 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.16 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Acetylcysteine |
4.48 | 19747007 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.94 | 11298694 11906362 2524372 12868966 14531868 8156756 8970840 18759878 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.47 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.61 | 3621924 2952479 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.69 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
15.69 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
15.69 | 7440962 16192314 6679447 18289764 18692083 6482804 9653073 9328219 9022650 1440618 8291058 18648102 11289319 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4-amino-2,6-dinitrotoluene |
15.69 | 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetylcysteine |
15.69 | 11287661 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
15.69 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
15.69 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
8.38 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
8.38 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.90 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.90 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.08 | 18230668 16714409 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.31 | 12538720 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
3.52 | 17359293 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.12 | 9294722 10568697 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.33 | 18037988 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.13 | 3581430 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.09 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
7.91 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
7.91 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.59 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
5.19 | 6705139 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.74 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.09 | 20067830 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.42 | 17150277 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
4.15 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.77 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.60 | 15692506 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.38 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.56 | 16330681 16244371 17875725 16495754 18674790 12587719 18006777 16244372 16707910 17888722 16144979 16879835 14766674 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
7.27 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
7.27 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.01 | 15692506 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.44 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.64 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.73 | 18467677 16221962 19772884 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.73 | 12621046 15340226 16120746 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.50 | 15147373 17606976 18501091 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.22 | 18606429 15340226 16354765 8697196 16959395 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.29 | 20558911 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
4.08 | 15034207 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.94 | 18670907 18850075 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.95 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.58 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.56 | 17937319 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
5.17 | 17296493 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.17 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.70 | 16306350 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
5.19 | 8074119 9022650 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.44 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
3.11 | 15369732 16775033 15699352 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.26 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
7.67 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.67 | 6582329 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.33 | 16085563 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.26 | 9327722 15034207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
3.50 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.50 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.50 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
7.55 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.55 | 20007298 15890375 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.55 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
14.68 | 2876784 6135515 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
14.68 | 3712494 1399818 6587162 598648 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
14.68 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
14.68 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Acetylcysteine |
8.54 | 12815614 |
MESH:D008171 |
Lung Diseases |
|
chromium hexavalent ion |
8.54 | 16775837 |
MESH:D008175 |
Lung Neoplasms |
|
chromium hexavalent ion |
3.70 | 16876463 16570259 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
3.70 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.70 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.54 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.88 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.70 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
3.10 | 15458769 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.30 | 16827129 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.10 | 17638057 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.61 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.94 | 17415656 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.64 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.85 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.85 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.11 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.03 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.01 | 18551238 7678174 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
9.89 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Acetylcysteine |
9.89 | 14720322 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
9.89 | 18259882 |
MESH:D009369 |
Neoplasms |
|
lycopene |
5.56 | 17051425 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.56 | 17405874 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.91 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.10 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.34 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
7.82 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
Acetylcysteine |
7.82 | 19446573 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.31 | 15555623 |
MESH:D009669 |
Nose Neoplasms |
|
chromium hexavalent ion |
5.27 | 16876463 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.84 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
15.77 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
15.77 | 6482804 4026338 |
MESH:D009784 |
Occupational Diseases |
|
4-amino-2,6-dinitrotoluene |
15.77 | 14694615 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
5.19 | 3988306 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.20 | 15930896 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.80 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.62 | 7296757 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.42 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.64 | 6228378 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.33 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.33 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.69 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.34 | 11118676 11896295 11399792 11222880 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.83 | 15749863 16729912 16868541 18437689 16888761 15897917 |
MESH:D011471 |
Prostatic Neoplasms |
|
lycopene |
3.83 | 17337101 15084515 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.47 | 16919318 15861022 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.36 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.43 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Acetylcysteine |
4.64 | 12210543 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.96 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.46 | 3692021 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.09 | 16767912 18313854 15625365 17710206 15675481 17203757 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.37 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.94 | 17846226 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.61 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
5.85 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.85 | 16192470 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.70 | 17203757 15625365 16767912 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.12 | 16709447 |
MESH:D013276 |
Stomach Ulcer |
|
Acetylcysteine |
4.10 | 17918041 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.74 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.25 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.08 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.54 | 1399818 6587162 6582329 7505956 3712494 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
7.54 | 16010429 17909728 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.57 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
8.57 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
8.57 | 17653716 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.47 | 10091137 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.42 | 14692618 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.77 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.65 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.36 | 17334414 17638931 17678736 16364871 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.42 | 15886252 |